CureVac N.V [NASDAQ: CVAC] closed the trading session at $5.48 on 2025-11-27. The day’s price range saw the stock hit a low of $5.26, while the highest price level was $5.49.
The stocks have a year to date performance of 106.02 percent and weekly performance of 4.98 percent. The stock has been moved at 18.36 percent over the last six months. The stock has performed 2.05 percent around the most recent 30 days and changed 2.05 percent over the most recent 3-months.
If compared to the average trading volume of 559.66K shares, CVAC reached to a volume of 5046623 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about CureVac N.V [CVAC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVAC shares is $5.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVAC stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for CureVac N.V shares, keeping their opinion on the stock as Hold, with their previous recommendation back on June 13, 2025. While these analysts kept the previous recommendation, Leerink Partners raised their target price from $12 to $4. The new note on the price target was released on April 25, 2024, representing the official price target for CureVac N.V stock. Previously, the target price had yet another raise to $13, while SVB Securities analysts kept a Outperform rating on CVAC stock. On January 19, 2023, analysts increased their price target for CVAC shares from 8 to 18.
The Price to Book ratio for the last quarter was 1.21, with the Price to Cash per share for the same quarter was set at 2.17.
CVAC stock trade performance evaluation
CureVac N.V [CVAC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.98. With this latest performance, CVAC shares gained by 2.05% in over the last four-week period, additionally plugging by 18.36% over the last 6 months – not to mention a rise of 60.70% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVAC stock in for the last two-week period is set at 63.17, with the RSI for the last a single of trading hit 0.12, and the three-weeks RSI is set at 0.08 for CureVac N.V [CVAC]. The present Moving Average for the last 50 days of trading for this stock 5.33, while it was recorded at 5.20 for the last single week of trading, and 4.57 for the last 200 days.
CureVac N.V [CVAC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and CureVac N.V [CVAC] shares currently have an operating margin of -238.99% and a Gross Margin at 64.94%. CureVac N.V’s Net Margin is presently recorded at 199.84%.
CureVac N.V (CVAC) Capital Structure & Debt Analysis
According to recent financial data for CureVac N.V. ( CVAC), the Return on Equity (ROE) stands at 17.68%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 14.14%, reflecting the company’s efficiency in generating profits from its assets. Additionally, CureVac N.V’s Return on Invested Capital (ROIC) is 15.29%, showcasing its effectiveness in deploying capital for earnings.
CureVac N.V (CVAC) Efficiency & Liquidity Metrics
Based on CureVac N.V’s (CVAC) latest financial statements, the Debt-to-Equity Ratio is 0.04%, indicating its reliance on debt financing relative to shareholder equity.
CureVac N.V (CVAC) Efficiency & Liquidity Metrics
From an operational efficiency perspective, CureVac N.V. (CVAC) effectively leverages its workforce, generating an average of $164760.94 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.70% and a Quick Ratio of 3.69%, indicating strong ability to cover short-term liabilities.
CureVac N.V [CVAC]: Institutional Ownership
There are presently around $10.42%, or 24.44%% of CVAC stock, in the hands of institutional investors. The top three institutional holders of CVAC stocks are: MILLENNIUM MANAGEMENT LLC with ownership of 2.87 million shares, which is approximately 1.2808%. POINT72 ASSET MANAGEMENT, L.P., holding 2.42 million shares of the stock with an approximate value of $$8.24 million in CVAC stocks shares; and POINT72 ASSET MANAGEMENT, L.P., currently with $$7.66 million in CVAC stock with ownership which is approximately 1.0047%.
